2022 annual financial data
Alnylam Pharmaceuticals 2022 Operating margin
Direct answer
Operating margin was -75.68%.
Operating income was -785,072,000 USD and net income was -1,131,156,000 USD.
Operating cash flow was -541,274,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,037,418,000 USD
- Operating income
- -785,072,000 USD
- Net income
- -1,131,156,000 USD
- Operating cash flow
- -541,274,000 USD